Standard BioTools fornisce indicazioni su EPS e ricavi futuri, offrendo agli investitori informazioni su quanto la società prevede di guadagnare nei prossimi periodi.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
11/04/2025 | LAB | Standard BioTools | FY | 2025 | — | — | — | $165.00M | $175.00M | $84.10M | |
08/11/2025 | LAB | Standard BioTools | FY | 2025 | — | — | — | $165.00M | $175.00M | $169.20M | |
05/06/2025 | LAB | Standard BioTools | FY | 2025 | — | — | — | $165.00M | $175.00M | $169.20M | |
02/26/2025 | LAB | Standard BioTools | FY | 2025 | — | — | — | $165.00M | $175.00M | $186.93M | |
01/13/2025 | LAB | Standard BioTools | Q4 | 2024 | — | — | — | $46.50M | $46.50M | $43.03M | |
01/13/2025 | LAB | Standard BioTools | FY | 2024 | — | — | — | $174.00M | $174.00M | $171.20M | |
10/30/2024 | LAB | Standard BioTools | FY | 2024 | — | — | — | $170.00M | $175.00M | $171.19M | |
07/31/2024 | LAB | Standard BioTools | FY | 2024 | — | — | — | $170.00M | $175.00M | $201.18M | |
05/08/2024 | LAB | Standard BioTools | FY | 2024 | — | — | — | $200.00M | $205.00M | — | |
02/28/2024 | LAB | Standard BioTools | FY | 2024 | — | — | — | $200.00M | $205.00M | — | |
01/08/2024 | LAB | Standard BioTools | FY | 2023 | — | — | — | $106.00M | $106.00M | — | |
01/08/2024 | LAB | Standard BioTools | Q4 | 2023 | — | — | — | $28.00M | $28.00M | — | |
11/07/2023 | LAB | Standard BioTools | FY | 2023 | — | — | — | $100.00M | $105.00M | $100.90M | |
10/04/2023 | LAB | Standard BioTools | FY | 2023 | — | — | — | $100.00M | $105.00M | $100.90M | |
05/09/2023 | LAB | Standard BioTools | FY | 2023 | — | — | — | $94.50M | $94.50M | — | |
01/09/2023 | LAB | Standard BioTools | FY | 2022 | — | — | — | $94.00M | $95.00M | — | |
01/09/2023 | LAB | Standard BioTools | Q4 | 2022 | — | — | — | $26.00M | $27.00M | — |
Negli ultimi mesi non sono state riportate guidance specifiche sulle vendite o sugli utili di Standard BioTools.
Sfoglia guidance e previsioni su tutte le azioni.